Endocrine Flashcards
Type 1 diabetes
Autoimmune disorder where insulin producing beta cells of islets of Langerhans in pancreas are destroyed by immune system leading to absolute insulin deficiency
classic triad of type 1 diabetes
weight loss, polydipsia (excessive thirst), polyuria
fatigue, blurred vision, candidal infection and sometimes DKA
type I diabetes Ix
• Fasting Glucose: 7.0 mmol/L • OGTT: 11.1 mmol/L • HbA1c: 48 mmol/L • Presence of islets autoantibodies o GAD, IA-2 and ZnT8 • C peptide – decrease after 3-5 year after diagnosis
type I diabetes Mx
carb counting, exercise, reduce drinking and stop smoking
Inuslin: basal/bolus
Insulin types
Rapid acting: Novorapid or Humalog – 5 hours: inject at start of meal or just after
Short acting: Humulin S, Actrapid – 6 hours
Intermediate acting: Humulin I (isophane), Insulatard – 12 hours
Long acting: Lantus, Levemir – 18 hours
Rapid acting analogue-intermediate mixture – Humalog Mix 25/50, Novomix30
Short acting-intermediate mixture – Humulin M3
plasma glucose levels
5-7 on waking
4-7 before meals
5-9 after meals at least 90 minutes after
Type II diabetes
Type 2 diabetes (due to a progressive loss of β-cell insulin secretion frequently on the background of insulin resistance)
Type II diabetes signs/symptoms
- Blurred vision
- Recurrent UTIs
- Tiredness
- Polyuria
- T2DM- Signs of complications- neuropathy, retinopathy and nephropathy
Pre-diabetes
Fasting: 6.1-6.9
OGTT: 7.8-11.0
HbA1c: 42-47
Diabetes management
lifestyle: exercise+diet: lose 5-10kg in a year
Monotherapy:
- Metformin + SU (intolerant of modified and standard release metformin)
combination: Met + SU or SLG2-inhibitor, DDP4 and pioglitazone
further combination: Met + SU + SLGT2, DDP4 or pioglitazone or injectable (GLP-1 agonist)
Further; Met + SU + SLGT2, DDP4 or pioglitazone or injectable (GLP-1 agonist + basal insulin )
o Once daily NPH (isophane – intermediate acting) Insulin is added to Metformin (+/- SU).
o If this is ineffective or becomes so then change to bd NPH insulin or mixed insulin (Humulin M3) or basal/bolus (e.g. Lantus and Novorapid)
BP 130/80: ACEi
Simvastatin 40mg or atrovastatin 10mg
Diabetic neuropathy
- Peripheral (stocking, absent ankle jerks, charcot joint, pes cavus, claw toes: 10g monofilament)
- autonomic
- proximal
- focal
Treated as neuropathic pain: amitriptyline, duloxetine, gabapentin or pregabalin
Diabetic nephropathy + Mx
damage to capillaries in glomeruli
- proteinuria
- diffuse scarring
- ACEi/ARB (dilation of renal efferent arterioles, decrease filtration pressure, GFR and proteinuria)
- SGL2 inhibitor
Microalbuminuria
ACR > 2.5 and >3.5 (female), PCR > 15 and negative dipstick
Proteinuria
ACR: >30 AND PCR >50 with positive dipstick
Diabetic retinopathy types
o Mild non-proliferative (Background)
o Moderate non-proliferative
o Severe non-proliferative
o Proliferative
diabetic retinopathy and maculopathy treatment
Retinopathy: (proliferative or maculopathy)
- Laser panretinal or macular grid photocoagulation
- viterectomy
Maculopathy:
1. Anti-VEGF medications
LADA
late-onset type 1 diabetes is probably quite common in patients presenting with ‘typical’ type 2 diabetes
ketosis = type 1 diabetes
DKA
Diabetic ketoacidosis (DKA) is a disordered metabolic state that usually occurs in the context of an absolute or relative insulin deficiency accompanied by an increase in the counter-regulatory hormones i.e. glucagon, adrenaline, cortisol and growth hormone.
Caused by uncontrolled lipolysis -> excess free fatty acids that are converted to ketone bodies. Dehydration, hyperglycaemia and hyperosmolar state (more electrolytes in the serum)
DKA precipitating factors
infection, missed insulin doses and MI
newly diagnosed type I diabetes
illicit and alcohol use
non-adherence to insulin
DKA diagnsis
Glucose: >11 Ketones > 3 or 5 and urine ketones (++) pH<7.3 metabolic acidosis K+ 5.5 mmol-1 Raised lactate, creatinine and amylase WCC: Median 25 Na: low Bicarbonate: <10
DKA management
- Fluid: 0.9% NaCl, glucose falls to 15, switch to dextrose
- Insulin: commence 6 units per hour IV and continue basal insulin (once per day) e.g. levemir
- Potassium: standard replacement is 40mmol/L IV fluid if K+ between 3.5 and 5 due to hypokalaemia
DKA complications
Hyperkalaemia or Hypokalaemia: Predispose to cardiac arrythmias
ARDS
Cerebral oedema
Gastric stasis
Hyperosmolar hyperglycaemic state (HHS)
Hyperosmolar hyperglycemic state is a metabolic complication of diabetes mellitus (DM) characterized by severe hyperglycemia, extreme dehydration, hyperosmolar plasma, and altered consciousness.
Osmotic diuresis, severe dehydration and electrolyte deficiency
HHS signs/symptoms
Fatigue, lethargy, Nausea and Vomiting, altered level of consciousness, headaches, papilloedema, weakness, hyperviscosity of blood -> CV events. Dehydration, hypotension, tachycardia.
HHS diagnosis
- Glucose over 50
- Hypovolaemia
- No ketonaemia
- Bicarbonate > 15
- ph >7.3
- osmolaity >320 (2xNa + urea + glucose). Normal = 275-295
HHS management
Careful fluid replacement – risk of fluid overload but try and replace/correct fluid deficit during the first 24 hours
o 3L+ve at 6 hours
o 3-6L+ve at 12 hours
Reduce glucose by 5mmol/hr and no more (prevent cerebral oedema and seizures)
Decreases osmolality 3-8 per hour
K+: 40mmol/L if K+ is between 3.5-5 due to treatment
Slower insulin or may not require (often glucose improves with fluids) e.g. 3 units/hour
Ketones > 1.0 then low dose 0.05 u/kg/hour
Sodium – avoid rapid fluctuations .g. ≤0.5mmol/l/hr and consider 0.45% Saline
Co-morbidities: screen vascular event or LMWH unless contradicted
STOP any SGLT2 inhibitors
Euglycaemic Keto-acidosis
Euglycemic diabetic ketoacidosis (EDKA) is a clinical triad comprising increased anion gap metabolic acidosis, ketonemia or ketonuria and normal blood glucose levels <200 mg/dL. This condition is a diagnostic challenge as euglycemia masquerades the underlying diabetic ketoacidosis.
Look for SGLT2i
Severe Alcohol-induced Keto-acidosis
Alcoholic ketoacidosis is a metabolic complication of alcohol use and starvation characterized by hyperketonemia and anion gap metabolic acidosis without significant hyperglycemia. Alcoholic ketoacidosis causes nausea, vomiting, and abdominal pain.
History: acomprosate
Severe Alcohol-induced Keto-acidosis Mx
- IV fluids (dextrose)
- IV pabrinex
- IV-antiemetics
Lactic acidosis
Type A: Tissue hypoxemia e.g. ischaemic bowel, cardiogenic and hypovolemic shock
Type B: associated with diabetes
Lactic acidosis management
Reduced bicarbonate Raised anion gap [(Na+ + K+) – (HCO3 + Cl-)]. Normal 10-18 Glucose variable – maybe [often] raised Absence of ketonaemia Raised phosphate
Treat underlying condition: Fluids and antibiotics
Withdraw offending medication
MODY
AD: genetic defect in B cell function
Types
• HNF-1α
• HNF-4α
• Glucokinase
MODY 2 (Glucokinase)
rate limiting step (glucokinase). Sensing defect, blood glucose threshold for inulin secretion is increased . Homeostatic point at 7 insead of 5
MODY 2 management
diet treatment
MODY 1 and 3
defects in HNF-1a, 1b and 4a.
Also regulate β cell differentiation and function
glycolytic flux, expression of GLUT2 transporters, cell growth, insulin secretion, glucose transport and metabolism
MODY 1 and 3 Mx
glicazide work on KATP channels
Neonatal diabetes
Kir6.2 mutations: constitutively activated KATP channels or an increase in KATP numbers
Transient or permanent
Neonatal diabetes Mx
SURs such as tolbutamide
Graves disease
Autoimmune disease: Antibodies bind to and activate thyrotropin receptors diffuse thyroid enlargement, increase in hormone production (T3) & react with orbital autoantigens
signs/symptoms of hyperthyroidism
Weight loss, ‘manic’, restlessness, heat intolerance, palpitations (even provoke arrhythmias), increased sweating, diarrhoea, oligomenorrhea, anxiety and tremor.
Graves disease signs/symptoms
- Exophthalmos and ophthalmoplegia
- Pretibial myxoedema
- Thyroid acropachy
- thyroid bruit
Graves diagnosis
TSH decrease and FT4/T3 increase
hypercalcaemia and ALP increase
Leukopenia
TRAb
Graves management
- Propranolol
- Carbimazole and PTU (1st trimester of pregnancy)
- Radioiodine treatment
- Thyroidectomy
- Mild eye disease (topically lubricants and steroids)
Carbimazole risk
aplasia cutis and agranulocytosis (fever, oral ulcer or oropharyngeal infection - do urgent FBC)
PTU risk
Liver failure and agranulocytosis (fever, oral ulcer or oropharyngeal infection - do urgent FBC)
Toxic multi nodular goitre
autonomously functioning thyroid nodules that secrete excess thyroid hormones
TMG signs/symptoms
Thyroid nodular and asymmetrical goitre
diagnosis TMG
FT4 increases and TSH decreases
Scintigraphy: high uptake
Thyroid USS: Exclude cancer
TRAb negative
Toxic adenoma
Solitary nodule producing T3 and T4.
Hot nodule on scintigraphy
Other causes of hyperthyroidism
- Ectopic thyroid tissue: follicular cancer (blood spread) or struma ovarii (ovarian teratoma with thyroid tissue)
Exogenous: iodine excess, contrast media and levothyroxine excess (T4 increases, T3 and thyroglobulin)
Subacute de Quervains thyroiditis: self-limiting post viral with painful goitre: associated neck tenderness, fever, viral symptoms, low isotpe scan and NSAIDs for treatment
Drug induced: amiodarone and lithium
Post-partum: In postpartum thyroiditis
Hashimotos thyroiditis
Autoimmune destruction of thyroid gland and reduced thyroid hormone production
Signs/symptoms of hypothyroidism
Weight gain, lethargy, cold intolerance, dry (anhidrosis), cold, yellowish skin. Non-pitting oedema e.g hands and face. Dry, coarse. Constipation. Menorrhagia. Decreased deep tendon reflexes and carpal tunnel syndrome
diagnosis of Hashimotos
TSH increase, FT4 decrease
MCV, CK, LDL increase
hyponatremia: decrease renal tubular water loss
hyperprolactinaemia: TRH increase leads to PRL increase
Anti-TPO antibodies
Hashimotos management
Younger patients: start levothyroxine at 50-100 μg daily. Review 12 weeks and adjust every 6 weeks by clinical state and to normalise it to suppress TSH
Elderly or IHD: start levothyroxine at 25-50 μg daily, adjusted every 4 weeks according to response. Cautiously as levothyroxine can cause angina or MI
Other causes of primary hypothyroidism
Goitrous
- iodine deficiency, drug (amiodarone, lithium) and maternal
Non-goitrous
- atrophic thyroiditis
- post ablative (radioidoine, surgery)
- Post radiotherapy
- congenital
Secondary hypothyroidism/hyperthyroidism causes
Diseases of the hypothalamus and pituitary gland (multiple!) o Infiltrative – sarcoid o Infectious o Malignant o Traumatic o Congenital o Cranial radiotherapy o Drug-induced
Subclinical hypothyroidism - when to treat
TPO positive
TSH > 10
past graves
pregnant
Subclinical hyperthyroidism
Treatment generally advised if TSH <0.1 (or if co-existing osteoporosis/fracture or AF)
Thyroid storm seen when?
hyperthyroid patients with an acute infection/illness, recent thyroid surgery, MI or radioiodine
signs/symptoms of thyroid storm
• Agitation, confusion, tachycardia, AF, D&V, goitre, thyroid bruit, acute abdomen and heart failure
Respiratory and cardiac collapse
• Hyperthermia
• Exaggerated reflexes
Thyroid storm management
Iugol’s iodine, glucocorticoids, beta blockers, PTU, fluids and monitoring